UMIN ID: UMIN000000494
Registered date:29/09/2006
Clinical study of influenza vaccine in infants; dose and immunogenicity
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | influenza |
Date of first enrollment | 2006/10/01 |
Target sample size | 200 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Influenza HA vaccine is inoculated twice at 4 weeks interval. Side reaction survey and antibody titer measurement are conducted after inoculations. |
Outcome(s)
Primary Outcome | HI titers before and after vaccination. Survey on side reaction after vaccination. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 6months-old |
---|---|
Age maximum | 48months-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1.Infants with a fever at the time of planned vaccination. 2.Infants with serious acute diseases. 3.Infants who has induced anaphylaxis by the substances of the vaccine. 4.Infants considered inappropriate to be inoculated vaccine. |
Related Information
Primary Sponsor | The Research Foundation for Microbial Diseases of Osaka University |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Health and Labour Sciences Research Grants |
Secondary ID(s) |
Contact
public contact | |
Name | |
Address | 2-13-16 Jigyo Chuo-ku, Fukuoka Japan |
Telephone | |
Affiliation | Medical Co. LTA Kyushu Clinical Pharmacology Research Clinic Clinical Pharmacology Department |
scientific contact | |
Name | Shin Irie |
Address | 2-13-16 Jigyo Chuo-ku, Fukuoka Japan |
Telephone | |
Affiliation | Medical Co. LTA Kyushu Clinical Pharmacology Research Clinic Clinical Pharmacology Department |